Picture of Ose Immunotherapeutics SA logo

OSE — Ose Immunotherapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Ose Immunotherapeutics Appoints Nicolas Poirier As CEO

Oct 7 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS APPOINTS NICOLAS POIRIER AS CHIEF
EXECUTIVE OFFICER
    * APPOINTMENT FOLLOWS DECISION OF BOARD OF DIRECTORS TO
TERMINATE
MANDATE OF ALEXIS VANDIER

Source text for Eikon:  ID:nBw58BKlCa 
Further company coverage:  OSE.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Ose Immunotherapeutics SA

See all news